WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Unveils New Drug Pricing Reform to Balance Innovation, Affordability and... China's State Council General Office has issued a landmark policy document, Several Opinions on Improving the Drug Price Formation Mechanism (Guobanfa [2026] No. 9), sett...
(4/14/2026)

China Deepens Opening of Biotech and Healthcar... (4/16/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (4/16/2026)

China's Pharma Innovators Pursue a Range of De... (4/15/2026)

China Private Biotech Funding Slows in Deal Co... (4/15/2026)

PhRMA Warns U.S. Drug Pricing Policies Could A... (4/14/2026)

How Big Pharma's China Trials Are Escaping Scr... (4/13/2026)

China Outbound Biopharma Licensing Surges as G... (4/13/2026)

China Backs Independent Pricing for Innovative... (4/9/2026)

China's Innovative Drug Out-Licensing Surge To... (4/9/2026)

Global Drugmakers Brace for Another Tough Chin... (4/8/2026)

Pharma Bets Big on Chinese Drugmakers (The Wir... (4/7/2026)

China NMPA Clears 17 Novel Drugs in First Quar... (4/7/2026)

Recent Official and Executive Moves (4/16/2026) China Poised to Trigger Global Price War... (4/16/2026) China Moves Toward Value-Based Drug Pric... (4/16/2026) CSPC Pharma's Tissue Factor ADC SYS6051 ... (4/16/2026) Aligos Signs Up to US$445M China HBV Dea... (4/16/2026) Adlai Nortye Secures US$150M Oversubscri... (4/16/2026) Evive Expands European Footprint as Ryzn... (4/16/2026) Bayer Secures China Approval for Hyrnuo ... (4/16/2026) Boehringer Ingelheim and Zai Lab Partner... (4/16/2026) Luofang Bio Raises Seed Funding to Advan... (4/16/2026) Mochida Partners with Qilu Pharma to Bri... (4/16/2026) Former Sinopharm Chairman Wei Yulin Sent... (4/16/2026) China Launches Nationwide Mental Health ... (4/16/2026) China CDE Opens Consultation on Draft CM... (4/16/2026) Biogen Maps Long-Term China Partnership ... (4/16/2026) Laekna's Phase 3 AKT Inhibitor Trial Del... (4/16/2026) Kailera Targets Up to US$528.5M Nasdaq I... (4/16/2026) China Drug Regulatory Weekly: Breakthrou... (4/16/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

AB-Raybio Raises ~CNY 100M to Advance Next-Gen RDC Pipe... Kailera Targets Up to US$528.5M Nasdaq IPO to Advance F... Biogen Maps Long-Term China Partnership Strategy as Cro... Mochida Partners with Qilu Pharma to Bring Follitropin ... Luofang Bio Raises Seed Funding to Advance Polymer Ther...

China CDE Opens Consultation on Draft CMC Guideline for... China Moves Toward Value-Based Drug Pricing, Granting G... China Unveils New Drug Pricing Reform to Balance Innova... China CDE Opens Public Consultation on Draft ARC CMC Gu... China CDE Releases Patient-Centered Clinical Developmen...

China Launches Nationwide Mental Health Coverage Push W... China Moves to Strengthen Community Healthcare and Expa... China Unveils Sweeping Measures to Accelerate Tiered He... NHSA Launches First Public Disclosure for Reference Dru... China Tightens Health Insurance Fund Oversight With New...

Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan... Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa...

India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac...

ArkBio Advances Global Influenza Ambitions as AK0406 Be... China Drug Regulatory Weekly: Breakthrough Oncology App... Laekna's Phase 3 AKT Inhibitor Trial Delivers Strong PF... Bayer Secures China Approval for Hyrnuo (Sevabertinib) ... CSPC Pharma's Tissue Factor ADC SYS6051 Cleared for Cli...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Former Sinopharm Chairman Wei Yulin Sentenced to 12 Yea... Recent Official and Executive Moves Former NMPA Chief Bi Jingquan Formally Prosecuted in Br... Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...